Company record
Aspire Pharmaceuticals, Inc.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Aspire Pharmaceuticals, Inc..
Warning letters
-
FoodAspire Pharmaceuticals, Inc.
FDA warning letter to Aspire Pharmaceuticals cites dietary supplement and drug CGMP violations, including falsified lab data and missing impurity testing.
High risk